Karyopharm Announces Publication of XPOVIO™ (Selinexor) Phase 2b STORM Study Results in The New England Journal of Medicine Nasdaq:KPTI

Press/Media

Period21 Aug 2019

Media coverage

1

Media coverage

  • TitleKaryopharm Announces Publication of XPOVIO™ (Selinexor) Phase 2b STORM Study Results in The New England Journal of Medicine Nasdaq:KPTI
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date21/08/19
    PersonsSundar Jagannath